Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 533.90
-3.30 (-0.61%)
Aug 24, 2026, 12:00 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 23.02 million as of August 24, 2026. Its market cap has decreased by -51.35% in one year.
Market Cap
23.02M
Enterprise Value
-3.98M
Revenue
1.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
533.90
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 23.02M, a decrease of -66.89%. That is a compound annual growth rate of -6.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 23.02M | -70.70% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 334.04M |
| Bonus BioGroup | 224.28M |
| Matricelf | 75.04M |
| BioLineRx | 41.94M |
| Clal Biotechnology Industries | 37.49M |
| BioLight Life Sciences | 23.74M |
| XTL Biopharmaceuticals | 20.64M |
| Purple Biotech | 18.65M |